Skip to search formSkip to main contentSkip to account menu

Xamoterol

Known as: (+-)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide, 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-, Xamoterol [Chemical/Ingredient] 
A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.
National Institutes of Health

Related topics

Related topics

13 relations

Broader (1)

Adrenergic beta-1 Receptor Agonists

Narrower (5)

CarwinCorwinICI-118587Xamoterol Fumarate
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Maintenance of beta-adrenergic receptor signaling can reduce Fas signaling in human retinal endothelial cells.
2009
2009
Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.
Three patients severely disabled from postural hypotension were treated with xamoterol, a selective beta-1-adrenoceptor… 
2001
2001
5-HT(7) receptor and beta(2)-adrenoceptor share in the inhibition of porcine uterine contractility in a muscle layer-dependent manner.
1993
1993
Partition and distribution coefficients of solutes and drugs in brush border membrane vesicles.
Review
1993
Review
1993
Controlled trials with beta blockers in heart failure: metoprolol as the prototype.
1992
1992
Selective and full β1‐adrenoceptor agonist action of a catechol derivative of denopamine (T‐0509) in the guinea‐pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline
1 The pharmacological actions of T‐0509, a 3‐hydroxy derivative of denopamine, were studied in various guinea‐pig tissues; these… 
1988
1988
Selectivity of xamoterol, prenalterol and salbutamol as assessed by their effects in the presence and absence of ICI 118 551.
Selectivity for beta 1- and beta 2-receptors to xamoterol, prenalterol and salbutamol were tested using ICI 118 551, a specific… 
1988
1988
Xamoterol
SummarySynopsisXamoterol is a partial agonist at the β1- adrenoceptor. Haemodynamic studies indicate that xamoterol moderately… 
1985
1985
Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.
The effect of xamoterol, a beta1 adrenoceptor partial agonist, on resting haemodynamic measurements and exercise tolerance was… 
1984
1984
Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol
Xamoterol is a new orally active partial β‐adrenoceptor agonist. Its kinetics, hemodynamic and metabolic effects, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)